These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20961774

  • 1. Drug-eluting tibial stents: objective patency determination.
    McMillan WD, Leville CD, Long TD, Gomes M, Groffsky JL, Schultz SR.
    J Vasc Interv Radiol; 2010 Dec; 21(12):1825-9. PubMed ID: 20961774
    [Abstract] [Full Text] [Related]

  • 2. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
    Giaquinta A, Vincenzo A, De Marco E, Veroux M, Veroux P.
    Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
    [Abstract] [Full Text] [Related]

  • 3. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
    Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL, Goshima KR, Echeverri JA, Arslan B.
    J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
    [Abstract] [Full Text] [Related]

  • 4. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [Abstract] [Full Text] [Related]

  • 5. Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia.
    Saqib NU, Domenick N, Cho JS, Marone L, Leers S, Makaroun MS, Chaer RA.
    J Vasc Surg; 2013 Mar; 57(3):692-9. PubMed ID: 23351646
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
    Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, Schmidt A, Tessarek J, Vinck E, Schwartz LB.
    J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
    [Abstract] [Full Text] [Related]

  • 7. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K, Ullery BW, Kret MR, Lee JT.
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [Abstract] [Full Text] [Related]

  • 8. Primary use of sirolimus-eluting stents in the infrapopliteal arteries.
    Rastan A, Schwarzwälder U, Noory E, Taieb FH, Beschorner U, Sixt S, Bürgelin K, Amantea P, Neumann FJ, Zeller T.
    J Endovasc Ther; 2010 Aug; 17(4):480-7. PubMed ID: 20681763
    [Abstract] [Full Text] [Related]

  • 9. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes.
    Varcoe RL, Schouten O, Thomas SD, Lennox AF.
    JACC Cardiovasc Interv; 2016 Aug 22; 9(16):1721-8. PubMed ID: 27539693
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents.
    Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnert T, Khan V.
    J Cardiovasc Surg (Torino); 2010 Apr 22; 51(2):183-91. PubMed ID: 20354488
    [Abstract] [Full Text] [Related]

  • 11. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
    Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S, Siablis D.
    J Endovasc Ther; 2011 Feb 22; 18(1):1-12. PubMed ID: 21314342
    [Abstract] [Full Text] [Related]

  • 12. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result.
    Hu H, Zhang H, He Y, Jin W, Tian L, Chen X, Li M.
    Ann Vasc Surg; 2011 Feb 22; 25(2):210-6. PubMed ID: 21315233
    [Abstract] [Full Text] [Related]

  • 13. Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
    Siablis D, Katsanos K, Karnabatidis D.
    J Endovasc Ther; 2010 Aug 22; 17(4):488-91. PubMed ID: 20681764
    [No Abstract] [Full Text] [Related]

  • 14. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
    Bosiers M, Callaert J, Keirse K, Hendriks JMH, Peeters P, Verbist J, Maene L, Beelen R, Deloose K.
    J Endovasc Ther; 2017 Jun 22; 24(3):311-316. PubMed ID: 28351310
    [Abstract] [Full Text] [Related]

  • 15. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jul 22; 66():595-600. PubMed ID: 31863948
    [Abstract] [Full Text] [Related]

  • 16. Retrograde pedal access for patients with critical limb ischemia.
    Bazan HA, Le L, Donovan M, Sidhom T, Smith TA, Sternbergh WC.
    J Vasc Surg; 2014 Aug 22; 60(2):375-81. PubMed ID: 24650744
    [Abstract] [Full Text] [Related]

  • 17. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
    Spreen MI, Martens JM, Knippenberg B, van Dijk LC, de Vries JPM, Vos JA, de Borst GJ, Vonken EPA, Bijlstra OD, Wever JJ, Statius van Eps RG, Mali WPTM, van Overhagen H.
    J Am Heart Assoc; 2017 Apr 14; 6(4):. PubMed ID: 28411244
    [Abstract] [Full Text] [Related]

  • 18. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.
    Brizzi V, Caradu C, Berard X, Sassoust G, Midy D, Ducasse E.
    J Cardiovasc Surg (Torino); 2018 Oct 14; 59(5):707-715. PubMed ID: 27879958
    [Abstract] [Full Text] [Related]

  • 19. What's next after optimal infrapopliteal angioplasty? Clinical and ultrasonographic results of a prospective single-center study.
    Gargiulo M, Maioli F, Ceccacci T, Morselli-Labate AM, Faggioli G, Freyrie A, Giovanetti F, Testi G, Muccini N, Stella A.
    J Endovasc Ther; 2008 Jun 14; 15(3):363-9. PubMed ID: 18540709
    [Abstract] [Full Text] [Related]

  • 20. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up.
    Donas KP, Torsello G, Schwindt A, Schönefeld E, Boldt O, Pitoulias GA.
    J Vasc Surg; 2010 Aug 14; 52(2):356-61. PubMed ID: 20541349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.